Psychedelics U.S. psychedelic drug market to reach $8.9B by 2029: DBMR report As rates of mental health disorders increase the demand for psychedelic treatments do too Rowan DunneJune 6, 2022
Industry update Attend next week’s psychedelics legalization debate Thursday, April 27, four experts including MAPS founder Rick Doblin and former US drug policy advisor Kevin Sabet debate the merits of psychedelic reform Nick LabaApril 16, 2021